[Detection of DPD exon 14 skipping before fluorouracil treatment].
Steiner
Michael
M
Universität Rostock, Institut für Klinische Chemie und Pathobiochemie, Rostock. micheal.steiner@med.uni-rostock.de
Schuff-Warner
Peter
P
Hartung
Gernot
G
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D000075202:Contraindications; D042943:Dihydrouracil Dehydrogenase (NADP); D005091:Exons; D005472:Fluorouracil / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D005787:Gene Frequency / Q000235:genetics; D006580:Genetic Carrier Screening; D005820:Genetic Testing; D005828:Genetics, Population; D005838:Genotype; D005858:Germany; D006801:Humans; D010088:Oxidoreductases / Q000235:genetics*; D017354:Point Mutation / Q000235:genetics*
D000964:Antimetabolites, Antineoplastic; D010088:Oxidoreductases; D042943:Dihydrouracil Dehydrogenase (NADP); D005472:Fluorouracil